Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01100593 · ClinicalTrials.gov registry record · NA
Ultrasound IV Study
A NA study of IV Access and Ultrasound Use, sponsored by Christiana Care Health Services.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
- 1
- Study location
NCT01100593: Completed NA study of IV Access and Ultrasound Use, sponsored by Christiana Care Health Services.
NCT01100593 is a NA study of IV Access and Ultrasound Use that has completed, run by Christiana Care Health Services. The registered enrollment target is 22 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01100593, a NA study of IV Access and Ultrasound Use, has completed, sponsored by Christiana Care Health Services.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare catheter length and extravasation rates for Ultrasound (US)-guided peripheral intravenous (IV) catheter insertion in a subset of emergency department patients with difficult IV access. Physicians, Emergency RNs, and Emergency Technicians can be taught to use US guidance to start peripheral IV in the ED. The optimal length of catheter to use for this procedure is unknown. This study will provide data on the length of catheter required to minimize extravasation. There is no guideline on catheter length selection for US-guided peripheral vascular access. This study may decrease extravasation rates for US-guided peripheral vascular access by providing guidance on catheter length selection.
Primary Outcome
compare catheter length and extravasation rates for US guided peripheral IV insertion in a subset of emergency department patients with difficult IV access
Conditions Studied
Interventions
- PROCEDURE length of IV catheter
Study Locations (1)
Delaware
- Christiana Care Health Services - Newark
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2009-06 |
| Est. Completion | 2009-11 |
| Phase | NA |
What the finished NCT01100593 record still lists
NCT01100593 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with IV Access appearing as the primary indexed condition, and to 1 intervention - of which length of IV catheter is the first listed.
NCT01100593 reports a single indexed study location in Delaware.
Frequently Asked Questions
What is clinical trial NCT01100593 about?
NCT01100593 is a clinical study titled "Ultrasound IV Study". The purpose of this study is to compare catheter length and extravasation rates for Ultrasound (US)-guided peripheral intravenous (IV) catheter insertion in a subset of emergency department patients with difficult IV access. Physicians, Emergency RNs, and Emergency Technicians can be taught to use U...
What is the current status of trial NCT01100593?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2009-06. Estimated completion is 2009-11.
What conditions does trial NCT01100593 study?
This clinical trial studies the following conditions: IV Access, Ultrasound Use.
What interventions are being tested in trial NCT01100593?
The interventions under investigation include: length of IV catheter (PROCEDURE).
Who is sponsoring clinical trial NCT01100593?
This trial is sponsored by Christiana Care Health Services, which has 82 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01100593 being conducted?
This trial has 1 study location across Delaware. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01100593's enrollment target sits among peer trials
22 1756th of 2000 higher than 239 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia